Real‐time continuous glucose monitoring improves postoperative glucose control in people with type 2 diabetes mellitus undergoing coronary artery bypass grafting: A randomized clinical trial
Diabetes, Obesity and Metabolism · 2025
DOI: 10.1111/dom.16177 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Diabetes, Obesity and Metabolism, 2025. Verfasst von Heejun Son und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Coronary Artery Bypass, Blood Glucose, Glycemic Control. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Han Jung Sik Family Fund, Korean Ministry of Food and Drug Safety in 2023.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Effective glycaemic control following cardiac surgery improves clinical outcomes, and continuous glucose monitoring (CGM) might be a valuable tool in achieving this objective. We investigated the effect of real‐time CGM and telemonitoring on postoperative glycaemic control in people with type 2 diabetes (T2D) after coronary artery bypass grafting (CABG).
Methods
In this randomized clinical trial (RCT), adults with T2D undergoing CABG were assigned to either a test group utilizing real‐time CGM (Dexcom G6) and telemetry for glycaemic control, or a control group with blinded CGM measures, relying on point‐of‐care measures. The primary outcome was the percentage of time in range (TIR) of blood glucose between 70 and 180 mg/dL (3.9–10.0 mmol/L), measured by CGM.
Results
Among 91 subjects, 48 were in the test group and 43 were in the control group. The least squares (LS) mean ± standard error of TIR was 60.3 ± 2.7%, 50.3 ± 2.9% in the test and control group, respectively. The test group had significantly higher TIR when adjusted with age, sex, body mass index, baseline fasting blood glucose and baseline glycated haemoglobin (LS mean difference, 10.0%; 95% confidence interval, 2.1–18.0; p = 0.014). The test group also had lower time above range and mean glucose levels, with no differences in time below range or hypoglycaemic events.
Conclusions
In this RCT, real‐time CGM and telemonitoring improved glycaemic control during postoperative period without increasing hypoglycaemia risk. Given the benefits of effective glycaemic control on perioperative outcomes, CGM may be helpful in managing T2D after CABG.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.
- Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
- Division of Endocrinology, Department of Internal Medicine, Veteran Health Service Medical Center, Seoul, Korea.
- Division of Endocrinology and Metabolism, Department of Internal Medicine, Hallym University Dongtan Sacred Heart Hospital, Hwaseong, Korea.
- Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.
- Department of Translational Medicine, Seoul National University College of Medicine, Seoul, Korea.
ORCID-Profile: Heejun Son, Suk Ho Sohn, Hyun Ah Kim, Young Min Cho, Ho Young Hwang, Soo Heon Kwak
Förderung
- Han Jung Sik Family Fund
- Korean Ministry of Food and Drug Safety in 2023
Zitieren
APA
Son, H., Sohn, S. H., Kim, H. A., Choe, H. J., Lee, H., Jung, H. S., Cho, Y. M., Park, K. S., Hwang, H. Y., & Kwak, S. H. (2025). Real‐time continuous glucose monitoring improves postoperative glucose control in people with type 2 diabetes mellitus undergoing coronary artery bypass grafting: A randomized clinical trial. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.16177
Vancouver
Son H, Sohn SH, Kim HA, Choe HJ, Lee H, Jung HS, et al. Real‐time continuous glucose monitoring improves postoperative glucose control in people with type 2 diabetes mellitus undergoing coronary artery bypass grafting: A randomized clinical trial. Diabetes, Obesity and Metabolism. 2025. doi:10.1111/dom.16177
BibTeX
@article{Son2025,
author = {Son, Heejun and Sohn, Suk Ho and Kim, Hyun Ah and Choe, Hun Jee and Lee, Hyunsuk and Jung, Hye Seung and Cho, Young Min and Park, Kyong Soo and Hwang, Ho Young and Kwak, Soo Heon},
title = {Real‐time continuous glucose monitoring improves postoperative glucose control in people with type 2 diabetes mellitus undergoing coronary artery bypass grafting: A randomized clinical trial},
journal = {Diabetes, Obesity and Metabolism},
year = {2025},
doi = {10.1111/dom.16177}
}
EUVIMED